Bookimed provides a platform for patients to find and connect with doctors specializing in laser eye surgery. The service includes online consultations and assistance in selecting medical specialists and clinics.

Evgeniy Kozlov

Bookimed

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Bernard Chauvin

Bausch + Lomb Corporation

SCHWIND eye-tech-solutions is a leading provider of advanced femtosecond laser technology, particularly known for its SCHWIND ATOS® system. This technology is used in refractive surgery to create LASIK flaps and lenticules for laser-assisted lenticular extraction, such as the SmartSight procedure. The company's products are praised for their precision, safety, and patient comfort, with features like low-energy delivery, eye tracking, and cyclotorsion compensation.

SCHWIND eye-tech-solutions

Bookimed | 2,020 followers on LinkedIn. The global hospital marketplace to find the medical solution and arrange the healthcare trip. | Bookimed is an outstanding universal platform for matching patients with first-rate healthcare centers and trip arrangements globally. 300,000 users of different nationalities visit the Bookimed website each month. Our mission is to give each patient access to the world&#39;s best therapeutic options to solve the medical problem. 

How do we achieve our goals?

Chairman Ukrainian Venture Capital&Private Equity association, founder AVentures Capital , WEF #YGL, cofounder EU Business hub, Investor in Spin.ai ,…

Andriy Kolodyuk

IT Teamlead – Bookimed

Александр Бунке

Medical Tourism Sales Manager

Hilal Özdemir Büyükaşık

Лидмейкер – Bookimed

Екатерина Парасюк

We’re #hiring a new Медичний координатор in Barcelona, Catalonia. Apply today or share this post with your network.

We’re #hiring a new Account Manager in Ukraine. Apply today or share this post with your network.

Dear community, Bookimed is actually looking for HR specialist in order to support our team. I’ll appreciate any references🙌

Metric
Company Name	Bookimed	Alcon Inc.	Bausch + Lomb Corporation	SCHWIND eye-tech-solutions
Symbol		ALC	BLCO
MSH ID	COM:BOOKIMED:US-UK	COM:ALCON	COM:BAUSCH	COM:EYE-TECH-SOLUTIONS
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services		Healthcare	Healthcare & Health Services
Industry	Medical Services		Medical - Instruments & Supplies	Medical Devices
Country	US	CH	CA	DE
Stage	Seed
Employee Count		25K	13.30K	124
Website	us-uk.bookimed.com/doctors	alcon.com	bausch.com	eye-tech-solutions.com
LinkedIn	bookimed			schwind-eye-tech-solutions
Founders

Metric
Market Cap		37.60B	5.43B
Enterprise Value
Monthly Web Traffic	691.38K	293
Web Traffic Growth	0.21	-0.72
Valuation
Raised Capital	500K

Metric
Revenue	9.46B	4.15B
Revenue (LTM)
Revenue (NTM)
Gross Profit	5.25B	2.50B
EBITDA	2.29B	601M
Operating Income	1.04B	130M
Net Income	974M	-260M
EPS	1.98	-0.74
Diluted EPS	1.98	-0.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.56	0.96
Operating Profit Margin	0.12	0.12
EBITDA Margin	0.24	0.14
Net Profit Margin	0.11	-0.00
Return on Equity	0.10	0.02
Return on Assets	0.04	-0.00
Return on Capital Employed	0.04	0.05

BOOK

COM:BOOKIMED:US-UK

Bookimed

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	82.75	-23.54
P/B Ratio	1.89	0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.16	1.64
EV Multiple	36.34	17.67

Metric
Days Sales Outstanding	66.36	72.01
Days Payables Outstanding	75.78	82.99
Days Inventory Outstanding	201.41	1.62K
Operating Cycle	282.86	1.70K
Cash Conversion Cycle	212.52	1.07K
Asset Turnover	0.32	0.34

Metric
Operating Cash Flow	1.39B	-17M
Free Cash Flow	537M	-198M
Cash Flow to Debt	0.36	0.05
Operating Cash Flow/Sales	0.19	0.13
Free Cash Flow Yield	0.01	-0.00

Metric
Cash & Equivalents	1.09B	331M
Accounts Receivable	-110M	-121M
Inventory	2.32B	1.03B
Goodwill	8.93B	4.58B
Debt to Capitalization	0.20	1.05
Debt to Assets	0.17	0.34
Current Ratio	1.87	1.78
Quick Ratio	1.56	1.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.02
R&D to Revenue	0.09	0.08
SG&A to Revenue